XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows
$ in Thousands, € in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Cash flows from operating activities:    
Net income $ 21,622 $ 13,787
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,607 6,333
Loss (gain) on disposal of property, plant & equipment 107 (6,209)
Share-based compensation 2,253 1,473
Deferred income taxes (466) (383)
Change in fair value of contingent consideration 3,051 6,002
Changes in operating assets and liabilities:    
Receivables, net (8,807) (16,363)
Inventories (9,448) (15,212)
Prepaid expenses and other current assets (1,395) (1,320)
Income taxes payable (1,470) (1,103)
Other assets 1,202 (3,004)
Accounts payable 4,862 11,832
Accrued expenses (6,197) 4,597
Deferred revenue (415) 1,365
Non-qualified deferred compensation plan and other liabilities 94 (1,830)
Net cash provided by (used in) operating activities 10,600 (35)
Cash flows from investing activities:    
Additions to property, plant, and equipment (4,951) (8,502)
Proceeds from sale of fixed assets 4 12
Net cash used in investing activities (4,947) (29,143)
Cash flows from financing activities:    
Proceeds from advances on revolving line of credit 9,000 34,000
Payments on revolving line of credit (5,000) (7,000)
Principal payments of long-term debt (2,000) (2,000)
Payment of contingent consideration (5,000) 0
Principal payments on finance lease obligations (32) (32)
Proceeds from exercise of stock options 680 21
Payment of statutory withholdings for restricted stock units vested (2,413) (1,302)
Net cash (used in) provided by financing activities (4,765) 23,687
Effect of foreign currency exchange rates on cash and cash equivalents (48) (50)
Net increase (decrease) in cash and cash equivalents 840 (5,541)
Cash and cash equivalents at beginning of period 4,451 11,117
Cash and cash equivalents at end of period 5,291 5,576
Advant Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired 0 (20,768)
DAS Medical [Member]    
Cash flows from investing activities:    
Acquisition, net of cash acquired $ 0 $ 115